Edward M. Kaye MD - Director at Stoke Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
STOK on Nasdaq
All Insider Reports
All Insider Reports

Edward M. Kaye MD - trading volume in the past year for Stoke Therapeutics, Inc.

Holdings reported by Edward M. Kaye MD for Stoke Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 49,124 $1,626,205 $33.10 08 Dec 2025 Direct
Restricted Stock Units 0 $1,190,880 $8.27 01 Dec 2025 Direct Common Stock
Performance Stock Units 0 $316,832 $12.07 03 Dec 2025 Direct Common Stock
Stock Option (Right to Buy) 542,801 08 Oct 2025 Direct Common Stock
Employee Stock Option (Right to Buy) 37,500 04 Sep 2025 Direct Common Stock

Transactions reported by Edward M. Kaye MD for Stoke Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.